市場調查報告書
商品編碼
1518784
全球細胞處理儀器市場 2024-2031Global Cell Processing Instrument Market 2024-2031 |
細胞處理儀器市場規模、佔有率和趨勢分析報告,按類型(細胞計數器、細胞成像系統、流式細胞儀、細胞分離器系統、自動化細胞處理系統和其他儀器)、按應用(細胞分離/分離、細胞影像和計數) 、細胞活力和增殖以及其他應用)以及最終用戶(製藥和生物技術公司、CRO 和 CMO、學術和研究機構等)預測期 (2024-2031)
預計在預測期內(2024-2031 年)細胞處理儀器市場將以 6.4% 的複合年成長率成長。細胞處理儀器是一種專門的工具,用於操作和製備用於各種目的的細胞,包括細胞療法、再生醫學和疫苗開發。它的重要性在於利用健康細胞來對抗疾病或修復受損組織。
Cell Processing Instrument Market Size, Share & Trends Analysis Report by Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments), by Application (Cell Isolation/Separation, Cell Imaging & Counting, Cell Viability & Proliferation, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, and Others) Forecast Period (2024-2031)
Cell processing instrument market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Cell processing instrument is a specialized tool used to manipulate and prepare cells for various purposes, including cell-based therapies, regenerative medicine, and vaccine development. Its importance lies in utilizing healthy cells to fight diseases or repair damaged tissues.
Market Dynamics
Increasing Government Support
Governments around the world are increasingly recognizing the potential of cell-based therapies and are providing financial support for R&D activities in this area. This support is helping to accelerate the development of new cell therapies and is also creating a more favorable market environment for cell processing instrument manufacturers. For instance, in February 2024, the NIH announced a new $200 million initiative to support research on gene editing for cell-based therapies. This funding will go towards developing safer and more effective gene therapies, which will rely heavily on advanced cell processing instruments.
Technological Advancements
Technological advancements are leading to the development of new and more sophisticated cell processing instruments. These instruments are making it possible to process cells more efficiently and effectively, which is essential for the development of cell-based therapies. For instance, in April 2023 Digitize Designs launched the RM-300 Automated Mobile 3D Scanning Inspection Workstation, a portable and affordable solution for manufacturing. The RM-300 integrates with the assembly line, making metrology and part inspection more accessible and eliminating common errors.
Market Segmentation
Cell Separator Systems is Projected to Emerge as the Largest Segment
The increasing demand for cell-based therapies and technological advancements in cell separator systems is a key contributor to the high share of this market segment. The increasing prevalence of chronic diseases and the role cell separators play in these therapies underscore the importance of these technologies.
However, the cell processing systems sub-segment is expected to grow over the coming years. Technological advancements in robotics, automation, and integration will enhance these systems' functionality and user-friendliness. Microfluidic cell processing systems, an emerging technology, offer advantages such as miniaturization, cost-effectiveness, precise control, and rapid prototyping and experimentation. They are attractive for small labs and point-of-care applications, with high growth potential driven by scalability needs.
The global cell processing instrument market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Holds Major Market Share
Among all the regions, North America holds a significant share of the global market. The presence of robust healthcare infrastructure, favorable regulatory environments, and high investments in R&D related to biotechnology are major contributors to the regional market share. Major manufacturers like Thermo Fisher Scientific and Danaher Corporation are headquartered in North America, allowing for faster innovation and market adaptation. The concept of personalized medicine is also gaining traction, further stimulating the cell processing instrument market across the region.
The major companies serving the global cell processing instrument market include Agilent Technologies Inc., Danaher Corp., Thermo Scientific Inc., Merck KGaA, and Beckman Coulter, Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May 2023, BD announced the commercial launch of BD FACSDiscover S8 Cell Sorter, a first-of-its-kind that uses a high-speed cell imaging system. Thus, this instrument features two technologies, which would enable researchers to understand cells more precisely and effectively.